About Coherus
Leadership Team
Board of Directors
Scientific Advisory Board
Strategic Advisory Board
Contact Us

Expanding Our Mission
Toripalimab Program

The Promise of Biosimilars
Unique Development Process
FDA Approval Process

Products & Pipeline
UDENYCA^® (pegfilgrastim-cbqv)
CIMERLI^® (ranibizumab-eqrn)
YUSIMRY™ (adalimumab-aqvh)
Coherus Solutions™
Medical Information

Investors

Join Our Team
Openings

Patient Support Services Contact Us

Educational Grants
Investigator Studies
Patient Support Services
Contact Us

About Coherus
Immuno-oncology
- Toripalimab Program
Biosimilars
- Unique Development Process
- FDA Approval Process
Products and Pipeline
Investors
Join Our Team
- Job Openings
Patient Support Services

Site Map

About Coherus
Immuno-oncology
Biosimilars
Products & Pipeline
Investors
Join Our Team
Privacy Policy
Contact Us

About Coherus
Immuno-oncology
- Toripalimab Program
Biosimilars
- Unique Development Process
- FDA Approval Process
Products and Pipeline
Investors
Join Our Team
- Openings
Privacy Policy
Contact Us

Coherus uses cookies on this website. They help us to know a little bit about you and how you use our website.

Privacy Policy
Site Map
Contact Us
Join Our Team

Copyright © 2023 Coherus BioSciences

Please click the links below to download PDF versions of the following documents:

Download Brand.com

For more information, please visit brand.com.

Visit Brand.com

For more information, please visit UDENYCA.com.

Visit UDENYCA.com